Application of overexpression of tox3 gene as a prognostic marker in liver cancer
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- PEOPLES HOSPITAL PEKING UNIV
- Publication Date
- 2021-09-24
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field
[0001] The present invention relates to the field of molecular biology, in particular, the application relates to TOX3 overexpression in the liver as prognostic markers. Background technique
[0002] Hepatocellular carcinoma (HCC) is the most common clinical, one of the most aggressive malignant tumors worldwide about 500,000 new patients every year, and increasing year by year. Liver blood vessels having multiple, highly malignant, fast growth rate, a wide range of transfer and high rate of recurrence, clinical treatment is not ideal. Treatment is most effective treatment for primary liver cancer is surgical resection, but a higher recurrence rate, tumor recurrence rate was 40% in five years, but at a late stage when the disease most patients treatment, because they do not meet the indications for surgical treatment and there is a high recurrence rate after the loss of the opportunity to question radical treatment, therefore, to seek new prognostic markers and po...